J695: Began Phase I testing

Cambridge Antibody Technology Group plc (LSE:CAT), Melbourn, U.K. Product: J695 Business: Autoimmune/Inflammation Therapeutic category: Antibody Target: IL-12 Description: Human monoclonal antibody a...